Giant Biogene Holding Co (HKSE:02367) Shares Outstanding (EOP): 1,054 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02367 Giant Biogene Holding Co Ltd HKSE:02367
85 GF Score
Price HK$24.46
GF Value HK$68.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Giant Biogene Holding Co Shares Outstanding (EOP)?

Giant Biogene Holding Co HKSE:02367 +1.24% 85 Shares Outstanding (EOP) is 1,054 Mil as of Dec. 2025. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.03 (Possible Value Trap). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Giant Biogene Holding Co's shares outstanding for the quarter that ended in Dec. 2025 was 1,054 Mil.

Giant Biogene Holding Co's quarterly shares outstanding declined from Jun. 2025 (1,071 Mil) to Dec. 2025 (1,054 Mil). It means Giant Biogene Holding Co bought back shares from Jun. 2025 to Dec. 2025 .

Giant Biogene Holding Co's annual shares outstanding increased from Dec. 2024 (1,016 Mil) to Dec. 2025 (1,054 Mil). It means Giant Biogene Holding Co issued new shares from Dec. 2024 to Dec. 2025 .


Giant Biogene Holding Co  (HKSE:02367) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Giant Biogene Holding Co Shares Outstanding (EOP) Related Terms


Giant Biogene Holding Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Giant Biogene Holding Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giant Biogene Holding Co Shares Outstanding (EOP) Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 976.00 976.00 981.64 1,015.95 1,053.89

Giant Biogene Holding Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 1,014.86 1,015.95 1,070.90 1,053.89 1,055.53

HKSE:02367 vs PG, CL, EL: Shares Outstanding (EOP) Comparison

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co Shares Outstanding (EOP) vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Shares Outstanding (EOP) falls into.


HKSE:02367
85GF Score
Giant Biogene Holding Co Ltd HKSE:02367
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giant Biogene Holding Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1,054 Mil mean?
Giant Biogene Holding Co (HKSE:02367) has a Shares Outstanding (EOP) of 1,054 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Giant Biogene Holding Co and its competitors.
Is Giant Biogene Holding Co's Shares Outstanding (EOP) too high?
Giant Biogene Holding Co's current Shares Outstanding (EOP) is 1,054 Mil. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Shares Outstanding (EOP) compare to PG and CL?
Giant Biogene Holding Co's Shares Outstanding (EOP) of 1,054 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Consumer Packaged Goods company?
A good Shares Outstanding (EOP) depends on the Consumer Packaged Goods industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Giant Biogene Holding Co and its competitors. Giant Biogene Holding Co's current Shares Outstanding (EOP) is 1,054 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.03, compared to a current price of HK$24.46 — trading 64% below its estimated fair value. The current Shares Outstanding (EOP) is 1,054 Mil. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Shares Outstanding (EOP) is 1,054 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?

Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued. The current stock price of HK$24.46 is trading 64% below its estimated GF Value™ of HK$68.03. GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.

Key valuation signals for HKSE:02367:

  • Shares Outstanding (EOP): 1,054 Mil
  • GF Value™: HK$68.03 vs. price of HK$24.46 (64% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Giant Biogene Holding Co Business Description

Address No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score

Get the complete analysis for HKSE:02367

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$24.46
Price
HK$68.03
GF Value